GMRE:NYE-Global Medical REIT Inc (USD)

COMMON STOCK | REIT - Healthcare Facilities |

Last Closing

USD 8.04

Change

+0.07 (+0.88)%

Market Cap

N/A

Volume

0.37M

Analyst Target

USD 14.79
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-21 )

Largest Industry Peers for REIT - Healthcare Facilities

Symbol Name Price(Change) Market Cap
WELL Welltower Inc

+4.33 (+3.35%)

USD 77.70B
VTR Ventas Inc

+1.39 (+2.36%)

USD 24.71B
DOC Healthpeak Properties Inc

+0.34 (+1.64%)

USD 14.53B
CTRE CareTrust REIT Inc.

+0.46 (+1.72%)

USD 5.07B
AHR American Healthcare REIT, Inc.

+0.03 (+0.11%)

USD 4.36B
NHI National Health Investors Inc

+1.04 (+1.50%)

USD 3.15B
LTC LTC Properties Inc

+0.43 (+1.23%)

USD 1.52B
CHCT Community Healthcare Trust Inc

+0.68 (+3.49%)

USD 0.55B
UHT Universal Health Realty Income..

+1.12 (+3.01%)

USD 0.52B
GMRE-PA Global Medical REIT Inc

+0.08 (+0.30%)

USD 0.41B

ETFs Containing GMRE

KBWY Invesco KBW Premium Yield.. 3.87 % 0.35 %

+0.08 (+0%)

USD 0.22B
GYLD Arrow ETF Trust 0.82 % 0.75 %

+0.02 (+0%)

USD 0.02B
SDEF 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (REIT - Healthcare Facilities) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 4.15% 67% D+ 69% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 4.15% 67% D+ 68% D+
Trailing 12 Months  
Capital Gain -21.87% 14% F 9% A-
Dividend Return 8.16% 79% B- 87% B+
Total Return -13.70% 14% F 12% F
Trailing 5 Years  
Capital Gain -46.18% 38% F 11% F
Dividend Return 27.71% 69% C- 79% B-
Total Return -18.47% 31% F 17% F
Average Annual (5 Year Horizon)  
Capital Gain -4.64% 36% F 13% F
Dividend Return 2.04% 36% F 31% F
Total Return 6.68% 86% B+ 91% A-
Risk Return Profile  
Volatility (Standard Deviation) 25.09% 43% F 44% F
Risk Adjusted Return 8.12% 36% F 26% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.